Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Chronic Hepatitis C Virus”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Post-approval studies (Phase 4)Study completedNCT01134952
What this trial is testing

Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
London Health Sciences Centre 11
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Post-approval studies (Phase 4)Study completedNCT04695769
What this trial is testing

Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

Who this might be right for
Chronic Hepatitis C
Helwan University 281
Post-approval studies (Phase 4)WithdrawnNCT02959359
What this trial is testing

DAA in the Risk of Recurrence After Curative Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan
Testing effectiveness (Phase 2)Study completedNCT01938625
What this trial is testing

Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 35
Large-scale testing (Phase 3)Ended earlyNCT00375895
What this trial is testing

Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Chronic Hepatitis CEvidence of Liver Transplantation
Rennes University Hospital 11
Early research (Phase 1)Study completedNCT00519792
What this trial is testing

Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment

Who this might be right for
Chronic Hepatitis C
Intarcia Therapeutics 60
Large-scale testing (Phase 3)Study completedNCT00378599
What this trial is testing

Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)

Who this might be right for
Liver TransplantationHepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 125
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Post-approval studies (Phase 4)Study completedNCT00375661
What this trial is testing

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

Who this might be right for
Hepatitis C, Chronic
Kyoto University 100
Not applicableStudy completedNCT03127358
What this trial is testing

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 11
Post-approval studies (Phase 4)Ended earlyNCT00641654
What this trial is testing

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
Göteborg University 75
Not applicableStudy completedNCT02824640
What this trial is testing

Patient-Centered Models of HCV Care for People Who Inject Drugs

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 755
Very early researchEnded earlyNCT00882193
What this trial is testing

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Who this might be right for
Chronic Hepatitis CGenotype 1Relapse
University of Nebraska 2
Large-scale testing (Phase 3)UnknownNCT00299923
What this trial is testing

Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, ChronicRelapse
University of Hamburg-Eppendorf 300
Testing effectiveness (Phase 2)Study completedNCT00695019
What this trial is testing

Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 169
Not applicableStudy completedNCT03197155
What this trial is testing

Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular CarcinomaHepatitis CDirect Acting Antivirals
Hospices Civils de Lyon 68
Large-scale testing (Phase 3)UnknownNCT03551444
What this trial is testing

Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial

Who this might be right for
Hepatocellular CarcinomaHepatitis C, Chronic
Ain Shams University 80
Not applicableNo Longer AvailableNCT02161939
What this trial is testing

Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb
Not applicableStudy completedNCT02440906
What this trial is testing

Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project

Who this might be right for
Chronic Mental IllnessChronic Physical Illness
University of Florida 1,663
Load More Results